Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports).

Authors	Ryuichi Kita, Yuri Kita-Sasai, Ikuko Hanaoka, Toru Kimura, Hiroyuki Kokuryu, Seigo Takamatsu, Yukio Osaki, Naomi Tomono, Tsutomu Hachiya, Tatsuo Shimizu
Journal	The American journal of gastroenterology (Am J Gastroenterol) Vol. 97 Issue 7 Pg. 1849-51 (Jul 2002) ISSN: 0002-9270 [Print] United States
PMID	12135056 (Publication Type: Case Reports, Letter)
Chemical References	Hypolipidemic Agents Bezafibrate
Topics	Adult Aged Bezafibrate (therapeutic use) Cholangitis, Sclerosing (drug therapy) Humans Hypolipidemic Agents (therapeutic use) Male Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!